You are here

  • Home
  • Archive
  • Volume 66, Issue 10
  • Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

Article metrics

Article menu

Download PDFPDF

XML
Hepatology
Original article
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016507419216
Aug 2016209208125
Sep 201612219791
Oct 20169213977
Nov 201613010947
Dec 20166913576
Jan 201714119492
Feb 20172023156
Mar 201726083
Apr 201703724
May 201714449
Jun 2017143730
Jul 2017404036
Aug 2017282836
Sep 2017439438137
Oct 201722321978
Nov 201721221354
Dec 201713113337
Jan 201817117045
Feb 201811711529
Mar 201866666433
Apr 201810810828
May 2018818325
Jun 2018808232
Jul 2018696924
Aug 2018868638
Sep 2018736924
Oct 2018737316
Nov 201810210227
Dec 2018818116
Jan 201967668
Feb 2019736919
Mar 2019828013
Apr 2019686418
May 2019625815
Jun 2019645827
Jul 2019636019
Aug 2019555338
Sep 2019595922
Oct 2019897713
Nov 2019636115
Dec 2019686413
Jan 2020514913
Feb 2020948614
Mar 202017817122
Apr 2020544912
May 2020534528
Jun 2020443718
Jul 2020423120
Aug 2020352111
Sep 202049237
Oct 2020423216
Nov 2020785810
Dec 2020544217
Jan 2021554719
Feb 2021342212
Mar 2021917912
Apr 202137339
May 202159577
Jun 2021161510
Jul 2021262615
Aug 2021373711
Sep 2021212015
Oct 2021373119
Nov 2021443422
Dec 2021322810
Jan 2022716018
Feb 202256549
Mar 202273674
Apr 20221061049
May 2022938718
Jun 2022605014
Jul 202251356
Aug 202236367
Sep 2022454120
Oct 202239399
Nov 2022473015
Dec 202222202
Jan 202315118
Feb 202358507
Mar 202334255
Apr 2023221613
May 2023211711
Jun 202322149
Jul 2023131116
Aug 2023171310
Sep 202315159
Oct 202324146
Nov 2023392314
Dec 202332309
Jan 202427256
Feb 2024251910
Mar 2024291957
Total725573502571